# \[e-drug\] HAI/Oxfam/MSF: Solutions to improve access to medicines **URL:** \ **Category:** e-drug\ **Created:** [November 24, 2014, 9:14am UTC](https://talk.edrugplus.org/t/e-drug-hai-oxfam-msf-solutions-to-improve-access-to-medicines/41167 "2014-11-24T09:14:57Z")\ **Posts on this page:** 1\ **Page:** 1
**Author:** ![Tessel\_Mellema](https://avatars.discourse-cdn.com/v4/letter/t/a3d4f5/32.png) [@Tessel\_Mellema](https://talk.edrugplus.org/u/Tessel_Mellema)\ **Post date:** [November 24, 2014, 9:14am UTC](https://talk.edrugplus.org/t/e-drug-hai-oxfam-msf-solutions-to-improve-access-to-medicines/41167/1 "2014-11-24T09:14:57Z")
E-DRUG: HAI/Oxfam/MSF: Solutions to improve access to medicines ---------------------------------------------------------------------------------------------------- HAI/Oxfam/MSF: Solutions to improve access to medicines and biomedical innovation through EU trade and R&D policy Citizens in developing countries have long suffered from a lack of access to affordable and effective medicines. As a result of the global financial crisis, a growing number of EU citizens are now experiencing similar problems. Better government policy could turn this around. The EU's current trade and R&D policies promote excessive intellectual property protection-an approach that drives up medicine costs and drives down needs-driven biomedical innovation. HAI Europe, Médecins Sans Frontières - Access Campaign and Oxfam are offering policy-makers seven straight-forward solutions that could transform harmful trade and R&D policy. By taking these solutions on board, the EU could enhance medicines access and pharmaceutical innovation in the EU and around the world. The solutions are available here: [http://haieurope.org/wp-content/uploads/2014/11/Solutions-to-improve-A2M-and-biomedical-innovation.pdf](http://haieurope.org/wp-content/uploads/2014/11/Solutions-to-improve-A2M-and-biomedical-innovation.pdf). For further information, please contact HAI Europe policy advisors, Tessel Mellema \ and Aliénor Devaliére \ Tessel Mellema Policy Advisor Health Action International (HAI) Europe Overtoom 60 (2) 1054 HK Amsterdam The Netherlands T: +31 (0) 20 683 3684 M: +31 (0) 6 24686771 Health Action International (HAI) Europe is an independent network working to increase access to essential medicines and improve their rational use through research excellence and evidence-based advocacy. E: tessel@haieurope.org